Thu, 02nd Aug 2018 18:15
LONDON (Alliance News) - Proteome Science PLC said Thursday that Vulpes Life Sciences Fund, a firm related to a non-executive director Martin Diggle, has bought shares in the company.
Diggle is a director of both Vulpes Life Sciences and Proteome.
Vulpes Life Sciences has purchased 328,000 shares in Proteome at 3.5 pence each.
Following this transaction, Vulpes now holds 56.4 million shares, equivalent to 19% holding.
Shares in Proteome closed up 6.2 % at 3.76p each.
(Alliance News) - Proteome Sciences PLC on Friday said it won a contract from an unnamed US biopharmaceutical company to use Proteome's mass spectrome...
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.
(Sharecast News) - Contract proteomics service Proteome Sciences has secured a contract win from a US biopharmaceutical company using the company's ma...
(Alliance News) - Stock prices in London opened higher on Friday, as investors shook off nerves ahead of US inflation data this afternoon.
(Alliance News) - Proteome Sciences PLC on Wednesday said it swung to a loss in 2023 on higher costs, and saw its revenue plunge on contract delays.
Proteome (PRM)